Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio — Expands portfolio to four marketed antibiotics, with peak sales potential over $1 billion —— Creates premier commercial stage global antibiotic franchise with the addition of Vabomere™(meropenem and...